Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Shoulder Innovations Q3 2026 Results: Net Loss of $7.05M, Loss Narrows

Shoulder Innovations, Inc. reported net revenue of $50.07 million for the nine months ended September 30, 2026, a significant increase from $32.90 million in the prior year period. Despite the revenue growth, the company incurred a net loss of $25.58 million for the period as it continues to invest heavily in research and development and selling, general, and administrative expenses.

Watch the Shoulder Innovations, Inc. earnings callFull call on the ALFA USA YouTube channel
Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue16.211.8
Gross profit12.79.0
Profit before tax-7.0-8.7
Net income-7.0-8.7
EPS (diluted, $ a share)$-0.34$-0.64

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+37.7%
Gross margin78.5%
Operating margin-46.9%
Source

10-Q filed with the SEC, NYSE: SI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Shoulder Innovations, Inc.: key numbers

Share price
$20.45Close, Nov 16
Market cap
$428M
Shares outstanding
20.92MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Shoulder Innovations, Inc.

All →
4:18 PM ET 8-K
Financial Results

Shoulder Innovations Financial Results

Shoulder Innovations reported Q3 2026 revenue of $16.2 million, a 38% year-over-year increase driven by higher implant system sales and surgeon adoption. The company raised its full-year 2026 revenue guidance to a range of $68 million to $70 million and highlighted the commercial launch of its N-22 humeral head.

“Our third quarter results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer base, and kept our product roadmap moving.”

Rob Ball, CEO of Shoulder Innovations

“This performance enabled us to again raise our outlook for the full year, and confirmed our conviction regarding our ability to grow market share through a differentiated approach to shoulder surgical care.”

Rob Ball, CEO of Shoulder Innovations
7:06 AM ET 8-K
Product Launch

Shoulder Innovations Product Launch

Shoulder Innovations announced the limited user release and commercial launch of InSet Go, its next-generation glenoid implant for anatomic shoulder arthroplasty. The launch follows the successful completion of the first surgical case and aims to improve procedural efficiency while maintaining the company's clinically-proven design for implant stability.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.